spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cardio3 BioScience 

 HSMN NewsFeed - 26 Nov 2014
Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure(R) for the Treatment of Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 1 Oct 2014
Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline
Regenerative Medicine
 HSMN NewsFeed - 9 May 2012
Cardio3 BioSciences Announces CE Marking for its C-Cath(R) Injection Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 29 Jun 2010
Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 16 Oct 2009
Clinical Center of Serbia, Institute for Cardiovascular Diseases Treats First Patient in Trial of Pioneering Stem Cell-Derived Therapy for Heart Failure
Regenerative Medicine Cardiology
 HSMN NewsFeed - 19 Jan 2009
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Regenerative Medicine Cardiology Venture Capital
 HSMN NewsFeed - 19 Nov 2008
Cardio3 BioSciences SA signs a co-development agreement with Artelis SA for the industrialization of the manufacturing process of C-Cure(TM) and inaugurate its new premises in Mont-Saint-Guibert
Regenerative Medicine Cardiology
 HSMN NewsFeed - 19 Nov 2008
Cardio3 BioSciences receives its accreditation number from the Belgian Federal Agency for Medicines and Health Products for the manufacture of C-Cure(TM) for human use
Regenerative Medicine Cardiology
 HSMN NewsFeed - 2 Oct 2007
Cardiac Stem Cell Therapy Company, Cardio3 BioSciences, Appoints Patrick Jeanmart as Its Chief Financial Officer (CFO)
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 24 Sep 2007
Cardiac Stem Cell Therapy Company, Cardio3 BioSciences, Appoints Former New Jersey Medical School Assistant Professor, Dr. Vinciane Gaussin, as its Chief Scientific Officer (CSO)
Regenerative Medicine Cardiology Personnel
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.